A haploid genetic screen identifies the key determinant of response to novel combination therapy with gemcitabine and entinostat in pancreatic cancer. This is an ASCO Meeting Abstract from the 2016 ...
Beaton, G. H., Selby, A. E., and Wright, A. M., J. Biol. Chem., 236, 2001 (1961).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results